Antimicrobial activities of new indole derivatives containing 1,2,4-triazole, 1,3,4-thiadiazole and carbothioamide; [1,2,4-triazol, 1,3,4-tiyadiazol ve karbotiyoamit içeren yeni indol türevlerinin antimikrobiyal aktiviteleri]
Özet
Objectives: In new antimicrobial drug development studies, indole and its derivatives create an important class of compounds. In addition, azoles and their derivatives were recognized to be associated with a variety of biologic activities such as antibacterial and antifungal. In this study antimicrobial activities of some indole derivatives mainly substituted with 1,2,4-triazole, 1,3,4-thiadiazole and hydrazinecarbothioamide were investigated to evaluate their efficacy. Materials and Methods: The efficacy of new compounds was evaluated using 2-fold serial dilutions against Staphylococcus aureus, MRSA, Escherichia coli, Bacillus subtilis, Candida albicans, and Candida krusei. Results: The MIC was determined for test compounds and for the reference standards sultamicillin, ampicillin, fluconazole, and ciprofloxacin. Conclusion: The compounds possessed a broad spectrum of activity having MIC values of 3.125-50 µg/mL against the tested microorganisms. This study provides valuable evidence that the indole-triazole derivative compound 3d holds significant promise as a novel antibacterial and antifungal lead compound. © Turk J Pharm Sci, Published by Galenos Publishing House.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Shirinzadeh, Hanif | |
| dc.contributor.author | Süzen, Sibel | |
| dc.contributor.author | Altanlar, Nurten | |
| dc.contributor.author | Westwell, Andrew D. | |
| dc.date.accessioned | 2026-10-18T20:28:49.611383483Z | |
| dc.date.available | 2026-10-18T20:28:49.611383483Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Objectives: In new antimicrobial drug development studies, indole and its derivatives create an important class of compounds. In addition, azoles and their derivatives were recognized to be associated with a variety of biologic activities such as antibacterial and antifungal. In this study antimicrobial activities of some indole derivatives mainly substituted with 1,2,4-triazole, 1,3,4-thiadiazole and hydrazinecarbothioamide were investigated to evaluate their efficacy. Materials and Methods: The efficacy of new compounds was evaluated using 2-fold serial dilutions against Staphylococcus aureus, MRSA, Escherichia coli, Bacillus subtilis, Candida albicans, and Candida krusei. Results: The MIC was determined for test compounds and for the reference standards sultamicillin, ampicillin, fluconazole, and ciprofloxacin. Conclusion: The compounds possessed a broad spectrum of activity having MIC values of 3.125-50 µg/mL against the tested microorganisms. This study provides valuable evidence that the indole-triazole derivative compound 3d holds significant promise as a novel antibacterial and antifungal lead compound. © Turk J Pharm Sci, Published by Galenos Publishing House. | |
| dc.description.sponsorship | The chemical synthesis part of this work was supported by the Scientific and Technological Research Council of Turkey (TUBİTAK) Research and Development Grant 112S599. | |
| dc.identifier.doi | 10.4274/tjps.55707 | |
| dc.identifier.eissn | 2148-6247 | |
| dc.identifier.endpage | 297 | |
| dc.identifier.issn | 1304-530X | |
| dc.identifier.issue | 3 | |
| dc.identifier.pmcid | PMC7227843 | |
| dc.identifier.pmid | 32454672 | |
| dc.identifier.scopus | 2-s2.0-85062059516 | |
| dc.identifier.startpage | 291 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/14032 | |
| dc.identifier.volume | 15 | |
| dc.identifier.wos | WOS:000450780900008 | |
| dc.language.iso | en | |
| dc.publisher | Turkish Pharmacists Association | |
| dc.relation.ispartof | Turkish Journal of Pharmaceutical Sciences | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | 1,2,4-triazole | |
| dc.subject | 1,3,4-thiadiazole | |
| dc.subject | C. krusei | |
| dc.subject | Indole | |
| dc.subject | MRSA | |
| dc.subject | 1,2,4 triazole derivative | |
| dc.subject | 1,3,4 thiadiazole derivative | |
| dc.subject | ampicillin | |
| dc.subject | carbothioamide | |
| dc.subject | ciprofloxacin | |
| dc.subject | fluconazole | |
| dc.subject | indole derivative | |
| dc.subject | sultamicillin | |
| dc.subject | unclassified drug | |
| dc.subject | antibacterial activity | |
| dc.subject | antifungal activity | |
| dc.subject | antimicrobial activity | |
| dc.subject | Article | |
| dc.subject | Bacillus subtilis | |
| dc.subject | bacterium culture | |
| dc.subject | Candida albicans | |
| dc.subject | drug analysis | |
| dc.subject | drug efficacy | |
| dc.subject | drug synthesis | |
| dc.subject | Escherichia coli | |
| dc.subject | methicillin resistant Staphylococcus aureus | |
| dc.subject | minimum inhibitory concentration | |
| dc.subject | nonhuman | |
| dc.subject | Pichia kudriavzevii | |
| dc.subject | Staphylococcus aureus | |
| dc.title | Antimicrobial activities of new indole derivatives containing 1,2,4-triazole, 1,3,4-thiadiazole and carbothioamide; [1,2,4-triazol, 1,3,4-tiyadiazol ve karbotiyoamit içeren yeni indol türevlerinin antimikrobiyal aktiviteleri] | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 45 | |
| rdl.citation.trdizin | 2 | |
| rdl.citation.wos | 38 | |
| rdl.department | ANKARA ÜNİVERSİTESİ | |
| rdl.department | Yabancı Kurumlar | |
| rdl.department | ERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ | |
| rdl.oa.status | gold | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | TRDIZIN | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Emerging Sources Citation Index (ESCI) |
